| CD8+ cytotoxic T lymphocytes in cancer immunotherapy: A review B Farhood, M Najafi, K Mortezaee Journal of cellular physiology 234 (6), 8509-8521, 2019 | 1226 | 2019 |
| Cyclooxygenase‐2 in cancer: a review N Hashemi Goradel, M Najafi, E Salehi, B Farhood, K Mortezaee Journal of cellular physiology 234 (5), 5683-5699, 2019 | 601 | 2019 |
| Extracellular matrix (ECM) stiffness and degradation as cancer drivers M Najafi, B Farhood, K Mortezaee Journal of cellular biochemistry 120 (3), 2782-2790, 2019 | 487 | 2019 |
| Macrophage polarity in cancer: a review M Najafi, N Hashemi Goradel, B Farhood, E Salehi, MS Nashtaei, ... Journal of cellular biochemistry 120 (3), 2756-2765, 2019 | 430 | 2019 |
| Cancer stem cells (CSCs) in cancer progression and therapy M Najafi, B Farhood, K Mortezaee Journal of cellular physiology 234 (6), 8381-8395, 2019 | 429 | 2019 |
| Cancer stem cell (CSC) resistance drivers M Najafi, K Mortezaee, J Majidpoor Life sciences 234, 116781, 2019 | 314 | 2019 |
| Mechanisms of apoptosis modulation by curcumin: Implications for cancer therapy K Mortezaee, E Salehi, H Mirtavoos‐mahyari, E Motevaseli, M Najafi, ... Journal of cellular physiology 234 (8), 12537-12550, 2019 | 271 | 2019 |
| Curcumin as an anti‐inflammatory agent: Implications to radiotherapy and chemotherapy B Farhood, K Mortezaee, NH Goradel, N Khanlarkhani, E Salehi, ... Journal of cellular physiology 234 (5), 5728-5740, 2019 | 226 | 2019 |
| Inflammasome: its role in traumatic brain and spinal cord injury K Mortezaee, N Khanlarkhani, C Beyer, A Zendedel Journal of cellular physiology 233 (7), 5160-5169, 2018 | 217 | 2018 |
| Steps in metastasis: an updated review J Majidpoor, K Mortezaee Medical Oncology 38 (1), 3, 2021 | 178 | 2021 |
| Tumor microenvironment: Interactions and therapy M Najafi, NH Goradel, B Farhood, E Salehi, S Solhjoo, H Toolee, ... Journal of cellular physiology 234 (5), 5700-5721, 2019 | 178 | 2019 |
| Contribution of regulatory T cells to cancer: A review M Najafi, B Farhood, K Mortezaee Journal of cellular physiology 234 (6), 7983-7993, 2019 | 172 | 2019 |
| The efficacy of PD-1/PD-L1 blockade in cold cancers and future perspectives J Majidpoor, K Mortezaee Clinical Immunology 226, 108707, 2021 | 146 | 2021 |
| Redox interactions and genotoxicity of metal-based nanoparticles: A comprehensive review K Mortezaee, M Najafi, H Samadian, H Barabadi, A Azarnezhad, ... Chemico-biological interactions 312, 108814, 2019 | 137 | 2019 |
| Melatonin as an adjuvant in radiotherapy for radioprotection and radiosensitization B Farhood, NH Goradel, K Mortezaee, N Khanlarkhani, E Salehi, ... Clinical and Translational Oncology 21, 268-279, 2019 | 135 | 2019 |
| Angiogenesis as a hallmark of solid tumors-clinical perspectives J Majidpoor, K Mortezaee Cellular Oncology 44, 715-737, 2021 | 131 | 2021 |
| Fusobacterium nucleatum and colorectal cancer: A mechanistic overview N Hashemi Goradel, S Heidarzadeh, S Jahangiri, B Farhood, ... Journal of Cellular Physiology 234 (3), 2337-2344, 2019 | 131 | 2019 |
| Transforming growth factor‐β signaling: tumorigenesis and targeting for cancer therapy A Ahmadi, M Najafi, B Farhood, K Mortezaee Journal of cellular physiology 234 (8), 12173-12187, 2019 | 128 | 2019 |
| Modulation of apoptosis by melatonin for improving cancer treatment efficiency: An updated review K Mortezaee, M Najafi, B Farhood, A Ahmadi, Y Potes, D Shabeeb, ... Life sciences 228, 228-241, 2019 | 121 | 2019 |
| CXCL12/CXCR4 axis in the microenvironment of solid tumors: A critical mediator of metastasis K Mortezaee Life sciences 249, 117534, 2020 | 117 | 2020 |
